242 related articles for article (PubMed ID: 25972231)
1. Oncostatin M is a potential agent for the treatment of obesity and related metabolic disorders: a study in mice.
Komori T; Tanaka M; Furuta H; Akamizu T; Miyajima A; Morikawa Y
Diabetologia; 2015 Aug; 58(8):1868-76. PubMed ID: 25972231
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of oncostatin M receptor β (OSMRβ) exacerbates high-fat diet-induced obesity and related metabolic disorders in mice.
Komori T; Tanaka M; Senba E; Miyajima A; Morikawa Y
J Biol Chem; 2014 May; 289(20):13821-37. PubMed ID: 24695736
[TBL] [Abstract][Full Text] [Related]
3. Oncostatin M in the development of metabolic syndrome and its potential as a novel therapeutic target.
Komori T; Morikawa Y
Anat Sci Int; 2018 Mar; 93(2):169-176. PubMed ID: 29103176
[TBL] [Abstract][Full Text] [Related]
4. Lack of oncostatin M receptor β leads to adipose tissue inflammation and insulin resistance by switching macrophage phenotype.
Komori T; Tanaka M; Senba E; Miyajima A; Morikawa Y
J Biol Chem; 2013 Jul; 288(30):21861-75. PubMed ID: 23760275
[TBL] [Abstract][Full Text] [Related]
5. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
6. Loss of Oncostatin M Signaling in Adipocytes Induces Insulin Resistance and Adipose Tissue Inflammation in Vivo.
Elks CM; Zhao P; Grant RW; Hang H; Bailey JL; Burk DH; McNulty MA; Mynatt RL; Stephens JM
J Biol Chem; 2016 Aug; 291(33):17066-76. PubMed ID: 27325693
[TBL] [Abstract][Full Text] [Related]
7. Oncostatin M: Potential Implications for Malignancy and Metabolism.
Stephens JM; Elks CM
Curr Pharm Des; 2017; 23(25):3645-3657. PubMed ID: 28677505
[TBL] [Abstract][Full Text] [Related]
8. Maresin 1 improves insulin sensitivity and attenuates adipose tissue inflammation in
Martínez-Fernández L; González-Muniesa P; Laiglesia LM; Sáinz N; Prieto-Hontoria PL; Escoté X; Odriozola L; Corrales FJ; Arbones-Mainar JM; Martínez JA; Moreno-Aliaga MJ
FASEB J; 2017 May; 31(5):2135-2145. PubMed ID: 28188173
[TBL] [Abstract][Full Text] [Related]
9. Macrophage migration inhibitory factor deficiency ameliorates high-fat diet induced insulin resistance in mice with reduced adipose inflammation and hepatic steatosis.
Finucane OM; Reynolds CM; McGillicuddy FC; Harford KA; Morrison M; Baugh J; Roche HM
PLoS One; 2014; 9(11):e113369. PubMed ID: 25412423
[TBL] [Abstract][Full Text] [Related]
10. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
Liu LF; Purushotham A; Wendel AA; Belury MA
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
[TBL] [Abstract][Full Text] [Related]
11. Oncostatin m is produced in adipose tissue and is regulated in conditions of obesity and type 2 diabetes.
Sanchez-Infantes D; White UA; Elks CM; Morrison RF; Gimble JM; Considine RV; Ferrante AW; Ravussin E; Stephens JM
J Clin Endocrinol Metab; 2014 Feb; 99(2):E217-25. PubMed ID: 24297795
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes.
Lee YS; Park MS; Choung JS; Kim SS; Oh HH; Choi CS; Ha SY; Kang Y; Kim Y; Jun HS
Diabetologia; 2012 Sep; 55(9):2456-68. PubMed ID: 22722451
[TBL] [Abstract][Full Text] [Related]
13. Blocking high-fat diet-induced obesity, insulin resistance and fatty liver by overexpression of Il-13 gene in mice.
Darkhal P; Gao M; Ma Y; Liu D
Int J Obes (Lond); 2015 Aug; 39(8):1292-9. PubMed ID: 25869601
[TBL] [Abstract][Full Text] [Related]
14. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
15. Coordinated improvement in glucose tolerance, liver steatosis and obesity-associated inflammation by cannabinoid 1 receptor antagonism in fat Aussie mice.
Bell-Anderson KS; Aouad L; Williams H; Sanz FR; Phuyal J; Larter CZ; Farrell GC; Caterson ID
Int J Obes (Lond); 2011 Dec; 35(12):1539-48. PubMed ID: 21386801
[TBL] [Abstract][Full Text] [Related]
16. Effect of acetylsalicylic acid on inflamed adipose tissue. Insulin resistance and hepatic steatosis in a mouse model of diet-induced obesity.
Sardi C; Martini E; Mello T; Camelliti S; Sfondrini L; Marcucci F; Kallikourdis M; Sommariva M; Rumio C
Life Sci; 2021 Jan; 264():118618. PubMed ID: 33141040
[TBL] [Abstract][Full Text] [Related]
17. A Role for Oncostatin M in the Impairment of Glucose Homeostasis in Obesity.
Piquer-Garcia I; Campderros L; Taxerås SD; Gavaldà-Navarro A; Pardo R; Vila M; Pellitero S; Martínez E; Tarascó J; Moreno P; Villarroya J; Cereijo R; González L; Reyes M; Rodriguez-Fernández S; Vives-Pi M; Lerin C; Elks CM; Stephens JM; Puig-Domingo M; Villarroya F; Villena JA; Sánchez-Infantes D
J Clin Endocrinol Metab; 2020 Mar; 105(3):e337-48. PubMed ID: 31606738
[TBL] [Abstract][Full Text] [Related]
18. CCR5 plays a critical role in obesity-induced adipose tissue inflammation and insulin resistance by regulating both macrophage recruitment and M1/M2 status.
Kitade H; Sawamoto K; Nagashimada M; Inoue H; Yamamoto Y; Sai Y; Takamura T; Yamamoto H; Miyamoto K; Ginsberg HN; Mukaida N; Kaneko S; Ota T
Diabetes; 2012 Jul; 61(7):1680-90. PubMed ID: 22474027
[TBL] [Abstract][Full Text] [Related]
19. Luteolin reduces obesity-associated insulin resistance in mice by activating AMPKα1 signalling in adipose tissue macrophages.
Zhang L; Han YJ; Zhang X; Wang X; Bao B; Qu W; Liu J
Diabetologia; 2016 Oct; 59(10):2219-28. PubMed ID: 27377644
[TBL] [Abstract][Full Text] [Related]
20. Epicatechin downregulates adipose tissue CCL19 expression and thereby ameliorates diet-induced obesity and insulin resistance.
Sano T; Nagayasu S; Suzuki S; Iwashita M; Yamashita A; Shinjo T; Sanui T; Kushiyama A; Kanematsu T; Asano T; Nishimura F
Nutr Metab Cardiovasc Dis; 2017 Mar; 27(3):249-259. PubMed ID: 28062181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
